Gregorio M. Bergonzi

Milan, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Safety and effectiveness of the combination of 5-azacitidine and ruxolitinib in VEXAS syndrome: A single-centre experience.

Safety and effectiveness of the combination of 5-azacitidine and ruxolitinib in VEXAS syndrome: A single-centre experience.

Journal: British journal of haematology

Published: September 18, 2025

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.

CC486 as a safe and effective bridge to transplant in MDS-del5q with transfusion-dependent anemia following lenalidomide relapse: A case report.

Journal: Current research in translational medicine

Published: May 26, 2025

Impact of letermovir on cytomegalovirus-specific T-cell reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era.

Impact of letermovir on cytomegalovirus-specific T-cell reconstitution after allogeneic hematopoietic stem cell transplantation in the post-transplant cyclophosphamide era.

Journal: Haematologica

Published: May 26, 2025

Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome.

Biomarkers for an early diagnosis of immune effector cell associated-hemophagocytic syndrome.

Journal: Frontiers in immunology

Published: May 25, 2025

Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.

Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.

Journal: Expert review of hematology

Published: May 21, 2025

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Validation of Manhattan risk to predict aGvHD severity in Rapamycin and PTCy-based prophylaxis: a study on 459 consecutive HCT patients.

Journal: Bone marrow transplantation

Published: March 03, 2025

Erythroid-stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort.

Erythroid-stimulating agents in VEXAS syndrome: A retrospective study from an Italian multicentre cohort.

Journal: British journal of haematology

Published: February 10, 2025

VEXAS associated acute disseminated Encephalo-Myelitis (ADEM)-like syndrome: A case report and review of the literature.

VEXAS associated acute disseminated Encephalo-Myelitis (ADEM)-like syndrome: A case report and review of the literature.

Journal: Current research in translational medicine

Published: January 06, 2025

Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19.

Clonal hematopoiesis of indeterminate potential associates with higher risk of thromboembolism in severe COVID-19.

Journal: Haematologica

Published: December 06, 2024

Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.

Methodology and clinical utility of longitudinal UBA1 tracking in VEXAS syndrome.

Journal: British journal of haematology

Published: September 17, 2024

Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.

Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.

Journal: Nature medicine

Published: July 08, 2024

Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura.

Role of next-generation sequencing in acquired amegakaryocytic thrombocytopenic purpura.

Journal: Current research in translational medicine

Published: January 18, 2024

Showing 1-12 of 13

Last Updated: 09/26/2026